APA   Click to copy
Neumann, M. A.-C., Schneider, J., Szameitat, M., Schommers, P., Borchmann, S., Hallek, M., … Heger, J.-M. (2026). Glofitamab crosses the blood-brain barrier and exhibits activity against primary and secondary CNS lymphoma. Blood Adv. https://doi.org/10.1182/bloodadvances.2025019322

Chicago/Turabian   Click to copy
Neumann, Marie Anne-Catherine, Jessica Schneider, Max Szameitat, Philipp Schommers, Sven Borchmann, Michael Hallek, Peter Borchmann, and Jan-Michel Heger. “Glofitamab Crosses the Blood-Brain Barrier and Exhibits Activity against Primary and Secondary CNS Lymphoma.” Blood Adv (2026).

MLA   Click to copy
Neumann, Marie Anne-Catherine, et al. “Glofitamab Crosses the Blood-Brain Barrier and Exhibits Activity against Primary and Secondary CNS Lymphoma.” Blood Adv, 2026, doi:10.1182/bloodadvances.2025019322.

@article{marie2026a,
  title = {Glofitamab crosses the blood-brain barrier and exhibits activity against primary and secondary CNS lymphoma},
  year = {2026},
  journal = {Blood Adv},
  doi = {10.1182/bloodadvances.2025019322},
  author = {Neumann, Marie Anne-Catherine and Schneider, Jessica and Szameitat, Max and Schommers, Philipp and Borchmann, Sven and Hallek, Michael and Borchmann, Peter and Heger, Jan-Michel}
}